Latest News and Press Releases

Admiral Group Plc (“Admiral”) 5 August 2022 Admiral announces that Jean Park, non-executive director, has returned from her temporary medical leave of absence to Board duties including as a member...

New York, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Tissue Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and...

New York, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial...

Tampa, Fla., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Toll Brothers, Inc (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to buy a new home at its Aspen Trail...

New York, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Clinical Trial Analysis by Trial Phase, Trial Status,...

New York, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pneumonia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status,...

Pune, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Medical Terminology Software Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size,...

Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 5 August 2022 — This document discloses the data of the transaction(s) made in Novo Nordisk...

NEW YORK, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

New York, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Chronic Urticaria Or Hives Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End...